Home Markets Clovis Oncology Announces Exercise by Existing Holder of Option to Purchase an...

Clovis Oncology Announces Exercise by Existing Holder of Option to Purchase an Additional $7.5 Million Aggregate Principal Amount of the Company’s 4.50% Convertible Senior Notes Due 2024

4
investorsdiurnal business news magazine

This post was originally published on this site

<style type="text/css">
<!–
.bwalignc { text-align: center; list-style-position: inside }
–>
</style>
<!– sh_cad_1 –>
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that pursuant to the terms of that previously announced Exchange and Purchase Agreement, dated as of November 4, 2020, by and between Clovis Oncology and an existing…